Clinical Trial Update: Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose [Phase 4]

View source ↗

Summary

This Phase 4 trial compares telmisartan to valsartan in adults with mild to moderate hypertension after a missed dose and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED